Neuropathy, High HbA1c, and Aspirin Use May Be Mortality Factors in ACCORD

A baseline hemoglobin A1c level that exceeds 8.5%, a prior clinical history of neuropathy, and/or use of aspirin may flag patients with type 2 diabetes who are at higher risk of mortality when very intensive glycemia treatment begins.